It has previously been reported that uterine nitric oxide (NO) production is enhanced during rat pregnancy compared to non-pregnant, labouring or postpartum states. The present hypothesis is that these changes in uterine NO production during pregnancy are caused by the interplay of oestrogen and progesterone. It is further postulated that changes in cyclic guanosine monophosphate (cGMP) production closely follow the changes in uterine NO synthesis. To test these hypotheses a variety of hormonal regimens (17β-oestradiol, progesterone and combinations) were applied to different rat models (prepubertal, non-pregnant intact and ovariectomized as well as pregnant rats). The production of nitric oxide (NO) as well as basal and in-vitro NO-stimulated cGMP tissue content were measured in parallel. NO production was measured by the accumulation of nitrites and nitrates in a 24 h incubation medium as analysed by Greiss reaction. cGMP content was measured by radioimmunoassay. Diethylenetriamine/NO (DETA/NO) was used as NO donor. NO production in the rat uterus was markedly increased by pregnancy compared to other physiological (prepubertal, or cycling dioestrus) and experimentally induced (OVX) states. In contrast, uterine cGMP was significantly decreased in pregnancy. Pregnancy also inhibited the elevation in uterine cGMP after in-vitro NO challenge. Chronic 17β-oestradiol treatment in prepubertal and/or OVX models increased NO production and also mimicked the effect of pregnancy on cGMP. Administration of progesterone in prepubertal rats induced a parallel decrease in both uterine NO and cGMP. In conclusion, sex steroid hormones distinctly regulate uterine NO and cGMP production depending upon the dose and regimen used, as well as the animal's reproductive state. Key words: guanylate cyclase/myometrium/nitric oxide/oestrogen/progesterone Introduction 1993) and lowers cytosolic calcium (Twort and vanBreemen, 1988). More recently, however, it has become increasingly Nitric oxide (NO) is synthesized from one of the terminal evident that, besides guanylate cyclase, NO has other possible guanidino nitrogens of L-arginine by the three isoforms of NO functional targets such as ion channels (Fukami et al., 1998; synthases (NOS). These NOS isoforms have been described Li et al., 1998) , soluble ADP-ribosylating enzymes (Brune in a variety of tissues including myometrium. Two of the and Lapetina, 1990) and transcription factors through which isoforms (endothelial, eNOS and neuronal, nNOS) are constitu-NO can directly affect gene transcription (Kroncke et al., tive, Ca 2ϩ calmodulin-regulated and the third isoform 1994) or mRNA translation via activation or deactivation (inducible, iNOS) is inducible, Ca 2ϩ calmodulin-independent.
Introduction
and lowers cytosolic calcium (Twort and vanBreemen, 1988) . More recently, however, it has become increasingly Nitric oxide (NO) is synthesized from one of the terminal evident that, besides guanylate cyclase, NO has other possible guanidino nitrogens of L-arginine by the three isoforms of NO functional targets such as ion channels (Fukami et al., 1998; synthases (NOS) . These NOS isoforms have been described Li et al., 1998) , soluble ADP-ribosylating enzymes (Brune in a variety of tissues including myometrium. Two of the and Lapetina, 1990) and transcription factors through which isoforms (endothelial, eNOS and neuronal, nNOS) are constitu-NO can directly affect gene transcription (Kroncke et al., tive, Ca 2ϩ calmodulin-regulated and the third isoform 1994) or mRNA translation via activation or deactivation (inducible, iNOS) is inducible, Ca 2ϩ calmodulin-independent. (Weiss et al., 1993) . On the other hand, the second messenger More importantly, these isoforms differ in the amounts of NO cGMP may arise from the activity of other enzymes besides they generate (i.e. picomoles for the constitutive and nanomoles the NO-stimulated soluble guanylate cyclase such as haefor the inducible NOS) (Berdeaux, 1993) . moxygenases, which stimulate the soluble guanylate cyclase via Initially it was believed that the sole target for NO is the carbon monoxide (Acevedo and Ahmed, 1998) or particulate haem moiety of the soluble guanylate cyclase, which contains guanylate cyclases, which are activated by peptide ligands protoporphyrin IX and iron in the ferrous form (Murad et al., (e.g. natriuretic peptides) (Foster et al., 1999 (Foster et al., ). 1990 ). Indeed, most of the physiological effects of NO can be Although there is strong evidence supporting the role of explained by activation of soluble guanylate cyclase which NO and NO-generated elevations in cGMP as regards smooth catalyses the formation of cyclic guanidine monophosphate muscle (i.e. vascular, airway, gastrointestinal) relaxation (cGMP) which in turn stimulates different kinases (Cornwell and Lincoln, 1989) , activates K ϩ channels (Robertson et al., (Moncada et al., 1991) , there is somewhat conflicting data on the involvement of the NO and/or cGMP pathway within the of reproductive function than changes in individual hormones, remain unclear. myometrium as a regulator of uterine quiescence or contractility
The present hypothesis is that oestrogen and progesterone (Sladek et al., 1997; Garfield et al., 1998a,b) . Several groups are major modulators of uterine NO production in both the reported on the relaxant effects of NO on myometrial contractilpregnant and non-pregnant states. It is further postulated that ity (Yallampalli et al., 1994; Buhimschi et al., 1995;  Izumi cGMP will follow closely the changes in uterine NO synthesis. and Garfield, 1995; Norman et al., 1997; Bradely et al., 1998;  To test these hypotheses the concentration-dependent effects Kuenzli et al., 1998; Ekerhovd et al., 1999) . However, a of oestrogen and progesterone were investigated, individually number of investigators have suggested that myometrial cGMP and in combination, on NO production and cGMP content in concentrations may not directly correlate either with NO the rat uterus using different animal models (prepubertal, nonconcentrations or with the degree of smooth muscle relaxation pregnant intact and ovariectomized as well as pregnant rats). (Nakatsu and Diamond, 1989; Weiner et al., 1994a; Kuenzli, 1998; Hennan and Diamond, 1998; Word and Cornwell, 1998) .
Materials and methods
It has previously been reported that uterine NO production is enhanced during rat pregnancy compared to non-pregnant, Animals and in-vivo treatments labouring or postpartum states (Yallampalli et al., 1994;  Animals were received in the animal care unit from Harlan Sprague Buhimschi et al., 1996) . Furthermore, there was an intriguing Dawley (Houston, TX, USA) and were allowed free access to food evolution in uterine NO production throughout gestation, with and water. They were housed in separate cages and maintained on a tissues collected on days 20 and 21 showing a further increase 12:12 h light:dark cycle. All procedures were approved by the Animal Care and Use Committee of the University of Texas Medical Branch.
in NO compared to earlier in pregnancy . Uteri during labour showed a much lower NO synthetic Timed pregnant rats activity compared to any time during pregnancy (Ali et al., Female nulliparous rats were received in the animal care unit on day 14 of gestation (day 0 ϭ sperm plug observed). For experiments 1996). It is well established that in the rat during the days evaluating nitrite production or cGMP content during gestation, before parturition there are critical alterations in hormone groups of animals were killled daily on day 18, 19, 20, 21, on the concentrations which enhance uterine contractility and initiate morning of day 22 (the expected day of delivery), during active labour (Garfield et al., 1998a) . The fall in progesterone labour (1-3 pups expelled) and on the morning of the first postpartum (progesterone withdrawal) which occurs after day 18 of gestaday. Uterine tissue was collected and processed for nitrite production tion in rats is complemented by the rise in oestrogen, which and cGMP content as described below. For experiments where the starts on day 20. Oestrogen concentrations remain highly effect of 17β-oestradiol on nitrite production or cGMP content was elevated before and during parturition on day 22 (Puri and evaluated, pregnant rats on day 17 of gestation were injected with Garfield, 1982) .
one dose of either 20 or 100 µg/kg 17β-oestradiol. Six hours later A link between steroid hormones (namely oestrogen and animals were killed and uterine tissues collected. The control group was injected with sesame oil. progesterone) and the NO-cGMP pathway exists in several tissues. During pregnancy myometrial quiescence in the rat Prepubertal rats coincides with elevated progesterone concentrations. PrevenPrepubertal rats were received on day 17 of life weighing 50-70 g and were weaned on day 19 of life. Beginning with day 21 of life, tion of progesterone withdrawal in rats prevents the fall in the following three regimens of injections were employed.
uterine NO production at term, whereas administration of Protocol 1. 17β-oestradiol, progesterone, 17β-oestradiol ϩ progesantiprogesterone before term induces a preterm decrease in terone, or vehicle were administered daily for 3 consecutive days.
myometrial NO Sladek and Roberts, 17β-Oestradiol was administered in doses of 1, 5, 20, 100 or 500 µg/ 1996). Earlier studies have also shown that while L-NAME kg/day. Progesterone was administered in doses of 10, 20 or 40 mg/ (N ω -nitro-L-arginine methyl ester), an inhibitor of NO synthesis, kg/day. For the combination, 17β-oestradiol (100 µg/kg/day) with does not induce preterm labour by itself, it does significantly progesterone (20 mg/kg/day) were injected simultaneously. The daily potentiate the effect of antiprogestins in inducing preterm dose was diluted in sesame oil and split into two injections, of 0.1ml parturition in rats . These studies each. All animals were killed on the morning of the fourth day by CO 2 inhalation immediately before uterine tissues were collected.
suggest that during rat pregnancy myometrial NO production Protocol 2. Prepubertal animals were first primed with 20 µg/kg is highly controlled by progesterone. In the non-pregnant state, 17β-oestradiol and 18 h later injected with a single dose of either 10, however, oestrogen seems to be the steroid hormone that 20 or 40 mg/kg progesterone diluted in 0.1 ml sesame oil. Control increases Ca 2ϩ -dependent NOS activity in a number of tissues animals received two injections of vehicle 18 h apart. Tissues were from female and male guinea-pigs (Weiner et al., 1994b) .
collected after 24 h from the progesterone injection.
However, depending on the animal model used, uterine NOS Protocol 3. Prepubertal rats were acutely injected with 20, 100 or activity (mainly Ca 2ϩ -dependent) was either unaffected 500 µg/kg 17β-oestradiol diluted in 0.2 ml sesame oil. Control (Weiner et al., 1994b) , decreased (Batra et al., 1998) or animals were injected with 0.2 ml oil only. Animals were killed after increased (Figueroa and Massmann, 1995) by oestrogen. In 2, 6 and 24 h from the oestrogen injection and uterine tissue collected.
the myometrium, at least, it is still not clear how sex steroid Non-pregnant intact rats hormones modulate NOS activity and whether cGMP exhibits Virgin rats weighing 150-170 g were separated by vaginal smear into concomitant changes. More importantly, the effects of alterathe three phases of oestrous cycle (dioestrus, pro-oestrous and oestrous) and uterine tissue was collected.
tions in oestrogen to progesterone ratio, a better determinant Total nitrites (nitrites ϩ reduced nitrates) produced by uterine tissues from pregnant animals during gestation (day 18: n ϭ 9; day 19: n ϭ 14; day 20: n ϭ 9; day 21: n ϭ 14; day 22NL, the morning of the delivery day: n ϭ 9), on day 22 during active labour (22L: 1-3 pups expelled: n ϭ 14) and the first day postpartum (pp1: n ϭ 7). n values represent the number of incubations which coincide with the number of animals in each group. Data are presented as percentage change (mean Ϯ SEM) from day 19. Statistical analysis: one-way analysis of variance (ANOVA) (P Ͻ 0.001) followed by multiple comparisons versus day 19 group using Dunnett's method. The bars with asterisk are significantly different from the day 19 group (P Ͻ 0.05). (B) Tissue cGMP content of full-thickness strips of uteri from pregnant animals during gestation (day 18: n ϭ 9; day 19: n ϭ 6; day 20: n ϭ 6; day 21: n ϭ 8; day 22NL: the morning of the delivery day; n ϭ 6), on day 22 during active labor (22L: 1-3 pups expelled; n ϭ 13) and the first day postpartum (pp1; n ϭ 5). Data are presented as percentage change (mean Ϯ SEM) from day 19. Statistical analysis: one-way ANOVA (not significant) followed by multiple comparisons versus day 19 group using Dunnett's method. There were no statistically significant differences versus day 19 values. (C) cGMP content (nmol/g) in uterine tissues of animals on day 19 of gestation and during labour (day 22L) in the absence (control: CRL) or presence of the NO donor diethylenetriamine/nitric oxide (DETA/NO; 0.1 mmol/l for 10 min). n ϭ 4 animals in each group. Student's t-tests between control and DETA/NO-treated showed no statistically significant differences.
Non-pregnant ovariectomized rats
the tissues were weighed before (wet weight) and after overnight drying at 60°C (dry weight). Virgin rats weighing 150-170 g were ovariectomized 14 days prior to drug administration. 17β-oestradiol was injected in doses of 10 or Nitrates in the medium were reduced to nitrites by the acid-treated cadmium method (Davison and Woof, 1978 ) using 300 mg Cd for 100 µg/kg/day for 3 days. The control group was injected with 0.2 ml sesame oil for 3 days. 0.7 ml medium diluted 1:3.5. Total nitrites (endogenous nitrites in the medium plus nitrites obtained after reduction of nitrates) were Tissue incubation and nitrite (NO 2 -) assay measured using the Greiss reaction (Green et al., 1982) . Briefly, 50 µl of Greiss reagent was added to 50 µl aliquots of reduced medium Pieces of uterine tissue (weighing 100-120 mg from mature animals and 60-80 mg from prepubertal rats) were rinsed thoroughly in and optical densities were measured at 550 nm in a microtitre plate using NaNO 2 as standards. The values obtained from the wells in minimum essential medium without phenol red (MEM; Gibco, Grand Island, NY, USA), and further cut with a scalpel blade in a relatively which medium alone had been incubated without tissue (non-tissue controls representing background non-specific optical density measconsistent number of full-thickness segments. In some of the treatment groups (e.g. control or progesterone-treated animals) it was necessary urements) were averaged for each incubation plate and the average subtracted from the values of each well containing tissue sample. to pool tissue from two different animals to accumulate the necessary mass of tissue. n values represent the number of incubations. The
The concentration of total nitrites in each well was normalized against the wet weight of the tissue. It had previously been observed that the tissue was further incubated in MEM with 1% antibiotics (penicillinstreptomycin, Gibco) in a CO 2 incubator with a humidified chamber major determinant of reproducibility is the reduction step. For this reason NaNO 3 aliquots at the same dilution as those used for the at 37°C for 24 h. Following incubation, the medium was collected, clarified by centrifugation at 16 000 g for 15 min at 4°C and stored standard curve were also run through the reduction process as an indication of efficacy. In addition, all samples from each individual at -70°C for a maximum of 2 weeks. In each 24-well incubation plate, at least two wells with medium only were incubated and experiment (the values presented in each figure panel) were reduced simultaneously and the results expressed as percentage of the values labelled as non-tissue controls. The 100-120 mg tissue from mature rats was incubated in 0.5 ml medium and the 60-80 mg tissue from from each control group. The control group comprised the animals treated with vehicle or, in the case of the non-pregnant cycling prepubertal rats was incubated in 0.4 ml medium. After incubation trichloroacetic acid. The homogenate was centrifuged at 10 000g for 15 min at 4°C. The pH of the supernatant was neutralized by the addition of excess CaCO 3 . The sample was then clarified by low speed centrifugation (1000 g) and aliquots were assayed for cGMP in duplicate by radioimmunoassay using a cGMP[ 125 I] assay system with Amerlex-M™ magnetic separation (Amersham, Arlington Heights, IL, USA). In some of the experiments we also measured cGMP concentration in the 10 ml incubation medium which was close to zero.
Chemicals used
All chemicals were purchased from Sigma (St. Louis, MO, USA) unless specified. DETA/NO was a kind gift from Dr L.Keifer (National Cancer Institute, Frederick, MD, USA). The Krebs solution was of the following composition (in mmol/l): 116 sodium chloride, 5.4 potassium chloride, 2.5 calcium chloride, 12 monosodium phosphate, 11.2 D-glucose, 22.0 sodium bicarbonate and had a pH of 7.4.
Statistical analysis
Results are expressed as mean Ϯ SEM. After subjecting all data sets to a test of normality (Kolmogorov-Smirnov), statistical comparisons between groups were performed using one-way analysis of variance (ANOVA) (parametric) or Kruskall-Wallis ANOVA on ranks (nonparametric) followed by Dunett's or Dunn's post-hoc tests (versus Figure 2. (A) Total nitrites (nmol/g nitrites ϩ reduced nitrates) produced by uterine tissues from animals during different control groups), or Student-Newman-Keuls (among multiple groups) physiological stages: immature (prepubertal: n ϭ 18 incubations as appropriate. A two-tailed P Ͻ 0.05 was used to denote statistical from 36 different animals); non-pregnant (NP) intact during significance. dioestrus (n ϭ 7 incubations and animals), pregnant (P) day 19 (n ϭ 14 incubations and animals) and non-pregnant ovariectomized (OVX: n ϭ 5 incubations and animals). Data are presented as mean 
Uterine NO and cGMP production during different physiological states
In order to examine the effect of hormonal manipulations on different animal models it was necessary to compare baseline concentrations (both for NO and cGMP) between these models. NO production by the rat uterus was markedly increased by the state of pregnancy when compared to other physiological (prepubertal: 52.71 Ϯ 9.7 nmol/g, n ϭ 18; cycling dioestrus: 27.14 Ϯ 5.1 nmol/g, n ϭ 7) and experimentally induced (49.8 Ϯ 5.1 nmol/g, n ϭ 5) states (Figure 2 ). In contrast, uterine cGMP content was significantly decreased by the state of pregnancy compared to immature (32.59 Ϯ 4.6 nmol/g, ϭ 7) or cycling dioestrus animals (27.14 Ϯ 5.1 nmol/g, n ϭ 7) To examine how changes in endogenous steroids may impact one-way analysis of variance (P ϭ 0.025) followed by comparisons on uterine NO and cGMP, the production of total NO 2 -and versus control group using Dunnett's method. The bar with asterisk cGMP content were measured during the stages of oestrous is significantly different from CRL at a level of P Ͻ 0.05. E 2 ϭ cycle and it was observed that the rat uterus during pro-oestrus 17β-oestradiol produced significantly more NO compared to during dioestrus and oestrus ( Figure 3A ). In contrast, cGMP content did not experiments were designed using hormonal manipulations in animals during different physiological states and NO and cGMP differ significantly between the three phases of the oestrus cycle ( Figure 3B ). Figure 3C illustrates the uterine cGMP were analysed in parallel. The results of these experiments will be described below.
content after 10 min exposure to 100 µmol/l DETA/NO, and it suggests that in the non-pregnant state exogenous NO is the highest dose (100 µg/kg). Interestingly, at a lower dose of oestrogen prepubertal animals were much more responsive on able to induce a significant increase in myometrial cGMP. This increase was of the same magnitude in both pro-oestrous and a percentage change basis. Unlike NO, cGMP content did not change significantly across the different oestradiol concentraoestrous animals.
tions ( Figure 5B ). When uterine strips were challenged in vitro Effects of hormonal manipulation in ovariectomized with NO ( Figure 5C and D), cGMP increased only in control rats animals which had not been injected with oestradiol. The increase seen in control uteri occurred only with the dose of 17β-oestradiol injection in ovariectomized animals resulted in a dose-dependent rise in NO production (Figure 4) . Whereas 100 mmol/l DETA/NO ( Figure 5C ) and as early as 1 min after the tissue was exposed to the NO donor ( Figure 5D ). In other 10 µg/kg/day 17β-oestradiol for 3 days produced only a small increase, the administration of 100 µg/kg/day 17β-oestradiol words the 3 day treatment with 17β-oestradiol rendered the prepubertal rat uterus unresponsive to the cGMP generating was followed by a sustained and statistically significant (P ϭ 0.025) increase in the nitrite production. ability of NO. Progesterone, when administrated alone for 3 days (Protocol Effects of hormonal manipulation in prepubertal rats 1) produced a decrease in the NO production which became statistically significant (P ϭ 0.031) with the highest dose Administration of 17β-oestradiol (1, 5 and 20 µg/kg/day) for 3 days (Protocol 1) produced a dose-dependent increase in of progesterone used (2 mg/kg/day). However, simultaneous administration of oestrogen and progesterone prevented the NO production in the rat uterus ( Figure 5A) . A decrease towards values not different from control was recorded with trend toward the decrease in NO ( Figure 6A ). Myometrial animals given progesterone 10, 20 or 40 mg/kg 18 h after priming animals), 1 mg/kg/day (n ϭ 11 from 18 animals), 2 mg/kg/day with one dose of 20 µg/kg 17β-oestradiol (progesterone 10 mg/kg: (n ϭ 10 from 17 animals) or the combination 17β-oestradiol 5 µg/ n ϭ 12 from 12 animals; progesterone 20 mg/kg: n ϭ 9 from 13 kg/day ϩ progesterone 1 mg/kg/day (n ϭ 6 from six animals).
animals; progesterone 40 mg/kg: n ϭ 12 from 16 animals). Control Control animals (CRL: n ϭ 18 from 36 animals) were injected with animals (CRL: n ϭ 18 from 35 animals) received two injections of vehicle. Treatments were carried out for 3 days prior to tissue vehicle 18 h apart. Statistical analysis: one-way analysis of variance collection. Statistical analysis: one-way analysis of variance (ANOVA) (P ϭ 0.001) followed by Dunnett's tests. The mean (ANOVA) (P ϭ 0.031) followed by Dunnett's tests. SEM) of full-thickness uterine tissues from prepubertal animals of full-thickness uterine tissues from prepubertal animals injected treated in vivo as described for A. n ϭ 7 in each group, with progesterone 0.5, 1 or 2 mg/kg/day for 3 days prior to tissue representing seven different animals. Statistical analysis: Kruskalcollection. Control animals (CRL) were injected with vehicle. n ϭ Wallis one-way ANOVA on ranks (P ϭ 0.037) followed by Dunn's 7 in each group representing seven different animals. Statistical tests. The means marked with asterisk are significantly different analysis: one-way ANOVA (P ϭ 0.001) followed by Dunnett's from control values (P Ͻ 0.05). P 4 ϭ progesterone. tests. The means marked with an asterisk are significantly different from control values (P Ͻ 0.01). P 4 ϭ progesterone.
to NO in vitro. Progesterone lowers uterine NO production and is also able to decrease uterine cGMP both in presence and absence of oestrogen priming. cGMP content was consistently decreased in animals treated with progesterone for 3 days compared to control animals To identify the time course of 17β-oestradiol on the stimulatory effect of NO production and inhibitory effect on cGMP, ( Figure 6B ). Since the effects of progesterone in an animal model without a prior exposure to oestrogen may seem an experiment was designed where prepubertal animals were injected acutely with 17β-oestradiol (three doses) and NO and controversial due to the lack of progesterone receptors, an experiment was also designed where the animals were primed cGMP were measured at 2, 6 or 24 h from the oestrogen injection (Protocol 3). It was possible to determine that at 6 h with a single dose of oestradiol 18 h prior to the administration of progesterone (Protocol 2). An increase in NO production ( Figure 8A ) with all doses used (20, 100 and 500 µg/kg) uterine NO production was significantly elevated (P Ͻ 0.01). was only observed when the lowest dose of progesterone (10 mg/kg) was used ( Figure 7A ). Myometrial cGMP content
The concentrations returned to normal after 24 h in the groups injected with 20 and 100 µg/kg. The highest dose produced a was again significantly decreased (P ϭ 0.037) by the two higher doses of progesterone (20 and 40 mg/kg) ( Figure 7B ). sustained increase in NO production, which remained statistically significant after 24 h (279.9 Ϯ 62.6%, P Ͻ 0.01). These results suggest that in prepubertal rats chronic oestrogen treatment increases uterine NO output while progesterone Myometrial cGMP content in these animals ( Figure 8B ) increased significantly (P Ͻ 0.01) only in the group injected opposes this effect. The increase in NO production is not paralleled by an increase in cGMP. Moreover, chronic oestrogen with the lowest dose of 17β-oestradiol (20 µg/kg) compared to the group of animals killed at time 0 (before injection). treatment induces a decrease in cGMP generation in response . NO production (A) and cGMP content (B) in uterine (B) in uterine tissues of prepubertal rats injected acutely with 17β-tissues of pregnant rats on day 17 of gestation injected acutely with oestradiol 20 µg/kg (circles), 100 µg/kg (squares) or 500 µg/kg 17β-oestradiol 20 or 100 µg/kg. Uterine tissues were collected 6 h (triangles). Uterine tissues were collected before (time 0) and at 2, after the acute administration of 17β-oestradiol. The control group 6 or 24 h after the acute administration of 17β-oestradiol. For NO (CRL) was injected with 0.2 ml sesame oil. n ϭ 6, representing six production (A) n ϭ 12, representing 12 different animals. For different animals in each group. Data are presented as mean Ϯ cGMP content (B) n ϭ 6, representing six different animals. Data SEM. Statistical analysis: one-way analysis of variance (there were are presented as mean Ϯ SEM. Statistical analysis: two-way no statistically significant differences in NO production or cGMP analysis of variance followed by Dunnett's tests: P Ͻ 0.001. The content). E 2 ϭ 17β-oestradiol. means marked with asterisk are significantly different from the NO or cGMP values before injection, respectively (P Ͻ 0.01). E 2 ϭ 17β-oestradiol. pregnancy compared to other physiological (prepubertal, or cycling dioestrus) and experimentally induced (ovariectomized) states. In contrast, uterine cGMP content was significantly This increase occurred as early as 2 h after injection. At 6 h decreased by pregnancy. Pregnancy also inhibited the elevation (when these tissues have the maximal NO-generating ability) in uterine cGMP after in-vitro NO challenge. (ii) Chronic cGMP content decreased significantly compared to concentraoestradiol treament in non-pregnant models mimics the effects tions recorded at the previous time point (2 h) both in the of pregnancy on NO and cGMP: NO production is generally groups injected with 20 and 100 µg/kg oestradiol. In animals increased by oestrogen with a dissociation in myometrial injected with the highest dose of oestradiol, cGMP content NO and cGMP production. In addition, oestrogen treatment showed a sustained trend towards a decrease despite the decreased the ability of NO to elevate cGMP in the rat uterus. sustained NO release by the myometrium.
(iii) Progesterone decreases NO and cGMP in parallel in the rat uterus and antagonizes the stimulatory effect of oestrogen NO and cGMP production in the pregnant uterus on NO production. These studies suggest that the increase in after administration of a single dose of oestrogen NO and decrease in cGMP during pregnancy in the uterus To investigate whether the same doses of 17β-oestradiol that may be a consequence of elevated oestradiol concentrations were able to elevate NO production (at 6 h) in the prepubertal during pregnancy. Moreover, steroid hormones may alter NO model would have a similar effect on the pregnant rat uterus, and cGMP production by a complex and intricate mechanism, pregnant animals were injected (on day 17 of gestation) with and a change in NO may not necessarily result in parallel 20 and 100 µg/kg 17β-oestradiol and the uteri sampled at 6 h. changes in cGMP. The effect of sex steroid hormones on It was observed that oestrogen was not able to affect NO uterine NO and cGMP production is complex and depends production if the animals were pregnant ( Figure 9A ). cGMP upon the animal model, dose and regimen used. was also unaltered by this hormonal manipulation in pregnant Previous studies have shown that NO inhibits uterine conanimals ( Figure 9B ). tractility both in isolated strips of pregnant myometrium as well as in vivo. Authentic NO gas, L-arginine (the substrate Discussion for NO) (Izumi et al., 1993; Yallampalli et al., 1994) and NO donors Sladek and Roberts, 1996 ; The results of the present study demonstrate that (i) NO production by the rat uterus was markedly increased by Ali et al., 1997) are all capable of inhibiting myometrial contractility. Previous studies have also shown that there is (NOS I and NOS III) are the primary isoforms responsible for NO production in the uterus ; Dong absolute elevation in the NO and cGMP production in the pregnant rat uterus (Yallampalli et al., 1994; Buhimschi et al., et al., 1996 Buhimschi et al., et al., , 1998 Zang et al., 1999) . During pregnancy, at least in the rat uterus, a marked elevation in iNOS occurs 1996) which declines at term. However, the evidence for an interaction between NO and cGMP systems within the Dong et al., 1996; Ali et al, 1997) . The uterine iNOS mRNA expression during pregnancy can be myometrial smooth muscle cell remains circumstantial. The action of NO on the myometrium may be through an effect further up-regulated by anti-oestrogens (Dong et al., 1998) . Therefore, it is possible that steroid hormones regulate the independent of soluble guanylate cyclase and/or the increase in myometrial cGMP content may be the result of activation various NOS isoforms differently. In the sheep uterus, where the NOS activity is mainly calcium-dependent both in the of particulate guanylate cyclases or haemoxygenases, both of which are expressed in the rat uterus (Acevedo and Ahmed, pregnant and non-pregnant states , oestrogens modulate the calcium-dependent NOS isoforms 1998; Vaillancourt et al., 1998) . The relationship between NO and cGMP can be even more intricate as several feedback (NOS I and NOS III) distinctively . Furthermore, in this study full-thickness uterine tissues were loops between NO and cGMP (Inoue et al., 1995; Miller et al., 1996) or between intracellular Ca 2ϩ and NO-induced cGMP used, which are comprised of many cell types including vasculature. Studies have been performed on the effect of synthesis (Xu et al., 1994) have been described at least for vascular smooth muscle cells. The present finding, that changes pregnancy and steroid hormones on uterine vasculature and have shown that the intense uterine vasodilation of pregnancy in cGMP in response to physiological states, sex steroid hormones or during the ovulatory cycle do not necessarily can be mimicked to some extent by oestrogen administration both in the non-pregnant sheep (cycling and steroid-treated) mirror changes in NO, is in support of separate mechanisms controlling NO and cGMP production in the uterus: NOS (Magness et al., , 1998 and postmenopausal women treated with steroid replacement therapy (Khorram et al., enzymes, guanylate cyclases and phosphodiesterases (the enzymes that degrade cGMP) may all be distinct targets of 1999). Therefore spatial changes in the relative expression of NOS isoforms between the myometrium, endometrium and hormonal modulation.
NOS enzymes, in particular the constitutive endothelial vasculature may explain the differences in NO production between physiological states as previously suggested (Magness isoform, are up-regulated both by the state of pregnancy and oestradiol treatment (Weiner et al., 1994b; Magness et al., et al., 1997 Magness et al., et al., , 1998 Khorram et al., 1999) . The discrepancy between the changes in NO and uterine 1997; Vagoni et al., 1998) . Khorram et al. (1999) has recently shown that both endogenous ovarian steroids and exogenous cGMP may also lie in the direct modulation of guanylate cyclases both by pregnancy and sex steroids. Weiner et al. sex hormones markedly influence uterine NOS expression in women with differential spatial responses in endometrium suggested that, in guinea-pigs, pregnancy induces a downregulation of soluble guanylate cyclase (the preferential source versus the myometrium.
The present data in non-pregnant and prepubertal animals of NO-stimulated cGMP) while increasing particulate guanylate cyclase activity (San Martin Clark et al., 1995) . Although suggest that oestrogen up-regulates NO production in the myometrium whereas progesterone opposes this effect. Hownot examined directly by the present study, a direct downregulation of soluble guanylate cyclase by pregnancy is also ever, when administered during pregnancy, the same dose of oestrogen does not have any consequences (Figure 9 ). One suggested by the current data [i.e. very low myometrial cGMP content during pregnancy compared to the other states analysed possible explanation is that pregnant animals have a much higher baseline NO production compared to prepubertal or ( Figure 2B ) and lack of cGMP elevation of pregnant uterus after exposure to DETA/NO in vitro ( Figure 1C) ]. This effect ovariectomized animals (Figure 2 ) (probably due to the very high endogenous oestrogens associated with pregnancy) and was entirely mimicked by oestrogen administration in the prepubertal model ( Figure 5C and D), suggesting that oestrogen the lack of response to exogenous oestrogens may mean that the tissue has already reached its maximal NO output that can may induce a selective down-regulation of the soluble guanylate cyclase in the rat uterus. Furthermore an altered cyclic be afforded by oestrogen. Interestingly, there may also be some degree of inhibition due to progesterone action, which nucleotide metabolism during pregnancy or steroid treatment by direct modulation of phosphodiesterase activity may add may explain why, after progesterone withdrawal occurs (on 19 of gestation in rats), NO production increases further (on to the discrepancies between NO and cGMP as the cGMP content measurements were performed in the absence phosphodays 20 and 21 of gestation: Figure 1) . However, the marked decrease in NO during parturition has to be induced by other diesterase inhibitors.
In conclusion it was found that NO production by the rat mechanisms that override the stimulatory effect of oestradiol on NO since it occurs in the presence of highly elevated uterus was markedly increased by pregnancy compared to other physiological (prepubertal, or cycling dioestrus) and/or oestrogen concentrations associated with the parturition process (Puri and Garfield, 1982) .
experimentally induced (ovariectomized) states. In contrast, uterine cGMP content was significantly decreased by pregAnother aspect that deserves comment, and may explain the differences in NO production among the physiological states nancy. Pregnancy also inhibited the elevation in uterine cGMP after in-vitro NO challenge. Chronic oestradiol treatment in studied, is the relative contribution of the three NOS isoforms to NO production in the uterus between the pregnant and nonnon-pregnant models generally mimics the effects of pregnancy on uterine NO and cGMP. Oestrogen up-regulates NO indepregnant states. Outside of pregnancy, the constitutive isoforms
